These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1177 related items for PubMed ID: 25925419

  • 1. US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines.
    Saraiya M, Unger ER, Thompson TD, Lynch CF, Hernandez BY, Lyu CW, Steinau M, Watson M, Wilkinson EJ, Hopenhayn C, Copeland G, Cozen W, Peters ES, Huang Y, Saber MS, Altekruse S, Goodman MT, HPV Typing of Cancers Workgroup.
    J Natl Cancer Inst; 2015 Jun; 107(6):djv086. PubMed ID: 25925419
    [Abstract] [Full Text] [Related]

  • 2. Prevention of Human Papillomavirus Infection. Beyond Cervical Cancer: A Brief Review.
    Medeiros R, Vaz S, Rebelo T, Figueiredo-Dias M.
    Acta Med Port; 2020 Mar 02; 33(3):198-201. PubMed ID: 32130098
    [Abstract] [Full Text] [Related]

  • 3. Potential impact of a nonavalent HPV vaccine on the occurrence of HPV-related diseases in France.
    Riethmuller D, Jacquard AC, Lacau St Guily J, Aubin F, Carcopino X, Pradat P, Dahlab A, Prétet JL.
    BMC Public Health; 2015 May 02; 15():453. PubMed ID: 25934423
    [Abstract] [Full Text] [Related]

  • 4. Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels.
    Jemal A, Simard EP, Dorell C, Noone AM, Markowitz LE, Kohler B, Eheman C, Saraiya M, Bandi P, Saslow D, Cronin KA, Watson M, Schiffman M, Henley SJ, Schymura MJ, Anderson RN, Yankey D, Edwards BK.
    J Natl Cancer Inst; 2013 Feb 06; 105(3):175-201. PubMed ID: 23297039
    [Abstract] [Full Text] [Related]

  • 5. Cancers attributable to human papillomavirus infection.
    Grulich AE, Jin F, Conway EL, Stein AN, Hocking J.
    Sex Health; 2010 Sep 06; 7(3):244-52. PubMed ID: 20719211
    [Abstract] [Full Text] [Related]

  • 6. Human papillomavirus genotype attribution for HPVs 6, 11, 16, 18, 31, 33, 45, 52 and 58 in female anogenital lesions.
    Serrano B, de Sanjosé S, Tous S, Quiros B, Muñoz N, Bosch X, Alemany L.
    Eur J Cancer; 2015 Sep 06; 51(13):1732-41. PubMed ID: 26121913
    [Abstract] [Full Text] [Related]

  • 7. Direct benefit of vaccinating boys along with girls against oncogenic human papillomavirus: bayesian evidence synthesis.
    Bogaards JA, Wallinga J, Brakenhoff RH, Meijer CJ, Berkhof J.
    BMJ; 2015 May 12; 350():h2016. PubMed ID: 25985328
    [Abstract] [Full Text] [Related]

  • 8. Using population-based cancer registry data to assess the burden of human papillomavirus-associated cancers in the United States: overview of methods.
    Watson M, Saraiya M, Ahmed F, Cardinez CJ, Reichman ME, Weir HK, Richards TB.
    Cancer; 2008 Nov 15; 113(10 Suppl):2841-54. PubMed ID: 18980203
    [Abstract] [Full Text] [Related]

  • 9. Human Papillomavirus-Attributable Cancers - United States, 2012-2016.
    Senkomago V, Henley SJ, Thomas CC, Mix JM, Markowitz LE, Saraiya M.
    MMWR Morb Mortal Wkly Rep; 2019 Aug 23; 68(33):724-728. PubMed ID: 31437140
    [Abstract] [Full Text] [Related]

  • 10. 9-Valent HPV vaccine for cancers, pre-cancers and genital warts related to HPV.
    Pitisuttithum P, Velicer C, Luxembourg A.
    Expert Rev Vaccines; 2015 Aug 23; 14(11):1405-19. PubMed ID: 26366475
    [Abstract] [Full Text] [Related]

  • 11. Targeting human papillomavirus to reduce the burden of cervical, vulvar and vaginal cancer and pre-invasive neoplasia: establishing the baseline for surveillance.
    Nygård M, Hansen BT, Dillner J, Munk C, Oddsson K, Tryggvadottir L, Hortlund M, Liaw KL, Dasbach EJ, Kjær SK.
    PLoS One; 2014 Aug 23; 9(2):e88323. PubMed ID: 24505474
    [Abstract] [Full Text] [Related]

  • 12. Human papillomavirus genotype distributions: implications for vaccination and cancer screening in the United States.
    Wheeler CM, Hunt WC, Joste NE, Key CR, Quint WG, Castle PE.
    J Natl Cancer Inst; 2009 Apr 01; 101(7):475-87. PubMed ID: 19318628
    [Abstract] [Full Text] [Related]

  • 13. Five-year relative survival for human papillomavirus-associated cancer sites.
    Razzaghi H, Saraiya M, Thompson TD, Henley SJ, Viens L, Wilson R.
    Cancer; 2018 Jan 01; 124(1):203-211. PubMed ID: 29105738
    [Abstract] [Full Text] [Related]

  • 14. Risk of human papillomavirus-associated cancers among persons with AIDS.
    Chaturvedi AK, Madeleine MM, Biggar RJ, Engels EA.
    J Natl Cancer Inst; 2009 Aug 19; 101(16):1120-30. PubMed ID: 19648510
    [Abstract] [Full Text] [Related]

  • 15. Vaccine-related HPV genotypes in women with and without cervical cancer in Mozambique: burden and potential for prevention.
    Castellsagué X, Klaustermeier J, Carrilho C, Albero G, Sacarlal J, Quint W, Kleter B, Lloveras B, Ismail MR, de Sanjosé S, Bosch FX, Alonso P, Menéndez C.
    Int J Cancer; 2008 Apr 15; 122(8):1901-4. PubMed ID: 18076064
    [Abstract] [Full Text] [Related]

  • 16. Human papillomavirus-associated cancers - United States, 2004-2008.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2012 Apr 20; 61():258-61. PubMed ID: 22513527
    [Abstract] [Full Text] [Related]

  • 17. Comprehensive control of human papillomavirus infections and related diseases.
    Bosch FX, Broker TR, Forman D, Moscicki AB, Gillison ML, Doorbar J, Stern PL, Stanley M, Arbyn M, Poljak M, Cuzick J, Castle PE, Schiller JT, Markowitz LE, Fisher WA, Canfell K, Denny LA, Franco EL, Steben M, Kane MA, Schiffman M, Meijer CJ, Sankaranarayanan R, Castellsagué X, Kim JJ, Brotons M, Alemany L, Albero G, Diaz M, de Sanjosé S, Authors of the ICO Monograph ‘Comprehensive Control of HPV Infections and Related Diseases’ Vaccine Volume 30, Supplement 5, 2012.
    Vaccine; 2013 Nov 22; 31 Suppl 8(0 8):I1-31. PubMed ID: 24229716
    [Abstract] [Full Text] [Related]

  • 18. [Anticipated efficacy of HPV vaccination in prophylaxis against nongenital cancers].
    Sehnal B, Vojáčková N, Driák D, Kmoníčková E, Vaňousová D, Maxová K, Neumannová H, Sláma J.
    Klin Onkol; 2014 Nov 22; 27(4):239-46. PubMed ID: 25115712
    [Abstract] [Full Text] [Related]

  • 19. HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women.
    Gillison ML, Chaturvedi AK, Lowy DR.
    Cancer; 2008 Nov 15; 113(10 Suppl):3036-46. PubMed ID: 18980286
    [Abstract] [Full Text] [Related]

  • 20. StatBite: Proportion of specific cancers caused by HPV.
    J Natl Cancer Inst; 2010 Jun 16; 102(12):839. PubMed ID: 20530763
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 59.